nach oben

Community Mental Health Journal

Erschienen in:

15.12.2016 | Original Paper

Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students’ Willingness to Counsel People Living with Mental Illness

verfasst von: Benita A. Bamgbade, Jamie C. Barner, Kentya H. Ford

Erschienen in: Community Mental Health Journal | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Third-year pharmacy students (n = 88) participated in an anti-stigma intervention program consisting of presentations, videos, discussion and active-learning exercises. Willingness to counsel (WTC) people with mental illness (MI) was evaluated using immediate pre and post-tests comparing diabetes, depression and schizophrenia. At pre-test, WTC diabetes was highest (higher = increased WTC) while schizophrenia was the lowest. There were no statistically significant differences between pre/post-test WTC for diabetes and depression, while schizophrenia WTC increased significantly (p < 0.05). At post-test, diabetes WTC was significantly higher than depression and schizophrenia (p < 0.0001). Regression results for WTC depression showed that comfortability and gender were significant (p < 0.05) predictors. Regression results for WTC schizophrenia showed that comfortability was a significant (p < 0.05) predictor. As highly accessible healthcare providers, pharmacists have the potential to positively impact healthcare, but this depends on WTC. Colleges of pharmacy may consider instituting policies that support experiential education involving counseling people living with MI, as this may increase comfortability.

Abdullah, T., & Brown, T. L. (2011). Mental illness stigma and ethnocultural beliefs, values, and norms: An integrative review. Clinical Psychology Review, 31(6), 934–948.CrossRefPubMed

Ajzen, I. (1985). From intentions to actions: A theory of planned behavior. Berlin: Springer.

Albarracin, D., Johnson, B. T., Fishbein, M., & Muellerleile, P. A. (2001). Theories of reasoned action and planned behavior as models of condom use: A meta-analysis. Psychological Bulletin, 127(1), 142.CrossRefPubMedPubMedCentral

Angermeyer, M. C., & Matschinger, H. (2003). Public beliefs about schizophrenia and depression: Similarities and differences. Social Psychiatry and Psychiatric Epidemiology, 38(9), 526–534.CrossRefPubMed

Bamgbade, B. A., Ford, K. H., & Barner, J. C. (2016). Impact of a mental illness stigma awareness intervention on pharmacy student attitudes and knowledge. American Journal of Pharmaceutical Education, 80(5), 80.

Bednall, T. C., Bove, L. L., Cheetham, A., & Murray, A. L. (2013). A systematic review and meta-analysis of antecedents of blood donation behavior and intentions. Social Science and Medicine, 96, 86–94.CrossRefPubMed

Bell, J., Aaltonen, S., Airaksinen, M., Volmer, D., Gharat, M., Muceniece, R., et al. (2009). Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. International Journal of Social Psychiatry, 56(1), 3–14.CrossRefPubMed

Bell, J. S., Aaltonen, S. E., Bronstein, E., Desplenter, F. A., Foulon, V., Vitola, A., et al. (2008). Attitudes of pharmacy students toward people with mental disorders, a six country study. Pharmacy World and Science, 30(5), 595–599.CrossRefPubMed

Bell, J. S., Johns, R., & Chen, T. F. (2006a). Pharmacy students’ and graduates’ attitudes towards people with schizophrenia and severe depression. American Journal of Pharmaceutical Education, 70(4), 77.CrossRefPubMedPubMedCentral

Bell, J. S., Johns, R., Rose, G., & Chen, T. F. (2006b). A comparative study of consumer participation in mental health pharmacy education. Annals of Pharmacotherapy, 40(10), 1759–1765.CrossRefPubMed

Bell, J. S., Whitehead, P., Aslani, P., Sacker, S., & Chen, T. F. (2006c). Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care. American Journal of Pharmaceutical Education, 70(2), 28.CrossRefPubMedPubMedCentral

Bell, S., McLachlan, A. J., Aslani, P., Whitehead, P., & Chen, T. F. (2005). Community pharmacy services to optimise the use of medications for mental illness: A systematic review. Australia and New Zealand Health Policy, 2(1), 29.CrossRefPubMedPubMedCentral

Black, E., Murphy, A. L., & Gardner, D. M. (2009). Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatric Services, 60(8), 1123–1127.CrossRefPubMed

Buhler, A. V., & Buhler, R. M. (2008). Peer-level patient presenters decrease pharmacy students’ social distance from patients with schizophrenia and clinical depression. American Journal of Pharmaceutical Education, 72(5), 106.CrossRefPubMedPubMedCentral

Cannon-Breland, M. L., Westrick, S. C., Kavookjian, J., Berger, B. A., Shannon, D. M., & Lorenz, R. A. (2013). Pharmacist self-reported antidepressant medication counseling. Journal of the American Pharmacists Association, 53(4), 390–399.CrossRefPubMed

Connery, H., & Davidson, K. M. (2006). A survey of attitudes to depression in the general public: A comparison of age and gender differences. Journal of Mental Health, 15(2), 179–189.CrossRef

Corrigan, P. W., Green, A., Lundin, R., Kubiak, M. A., & Penn, D. L. (2001). Familiarity with and social distance from people who have serious mental illness. Psychiatric Services, 52(7), 953–958.CrossRefPubMed

Crisp, A. H., Gelder, M. G., Rix, S., Meltzer, H. I., & Rowlands, O. J. (2000). Stigmatisation of people with mental illnesses. British Journal of Psychiatry, 177(1), 4–7.CrossRefPubMed

Fancher, T. L., Lee, D., Cheng, J. K. Y., Yang, M. S., & Yang, L. (2014). Interventions to improve adherence to psychotropic medication in clients of Asian descent: A systematic review. Asian American Journal of Psychology, 5(1), 22.CrossRef

Finley, P. R., Crismon, M. L., & Rush, A. J. (2003). Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 23(12), 1634–1644.CrossRef

Gabbidon, J., Clement, S., van Nieuwenhuizen, A., Kassam, A., Brohan, E., Norman, I., et al. (2012). Mental Illness: Clinicians’ Attitudes (MICA) Scale—psychometric properties of a version for healthcare students and professionals. Psychiatry Research, 206(1), 81–87.CrossRefPubMed

Hagger, M. S., Chatzisarantis, N. L. D., & Biddle, S. J. H. (2002). A meta-analytic review of the theories of reasoned action and planned behavior in physical activity: predictive validity and the contribution of additional variables. Journal of Sport and Exercise Psychology, 24(1), 3–32.CrossRef

Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Archives of General Psychiatry, 62(10), 1097–1106. doi:10.1001/archpsyc.62.10.1097.CrossRefPubMed

Hoch, M. A., Ott, C. A., Hudmon, K. S., & Plake, K. S. (2011). Attitudes of individuals with schizophrenia toward pharmacists. Journal of the American Pharmacists Association: JAPhA, 52(6), 783–786.CrossRef

Jorm, A. F., Korten, A. E., Jacomb, P. A., Christensen, H., & Henderson, S. (1999). Attitudes towards people with a mental disorder: A survey of the Australian public and health professionals. Australian and New Zealand Journal of Psychiatry, 33(1), 77–83. doi:10.1046/j.1440-1614.1999.00513.x.CrossRefPubMed

Julius, R. J., Novitsky, M. A. Jr., & Dubin, W. R. (2009). Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice, 15(1), 34–44.CrossRefPubMed

Kassam, A., Papish, A., Modgill, G., & Patten, S. (2012). The development and psychometric properties of a new scale to measure mental illness related stigma by health care providers: The Opening Minds Scale for Health Care Providers (OMS-HC). BMC Psychiatry, 12(1), 62.CrossRefPubMedPubMedCentral

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. doi:10.1001/archpsyc.62.6.593.CrossRefPubMed

Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., & Nelson, C. B. (1993). Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders, 29(2), 85–96.CrossRefPubMed

Krueger, J. L., & Hermansen-Kobulnicky, C. J. (2010). Patient perspective of medication information desired and barriers to asking pharmacists questions. Journal of the American Pharmacists Association: JAPhA, 51(4), 510–519.CrossRef

Lauber, C., Nordt, C., Falcato, L., & Rössler, W. (2004). Factors influencing social distance toward people with mental illness. Community Mental Health Journal, 40(3), 265–274.CrossRefPubMed

Liekens, S., Smits, T., Laekeman, G., & Foulon, V. (2012a). Factors determining social distance toward people with depression among community pharmacists. European Psychiatry, 27(7), 528–535.

Liekens, S., Smits, T., Laekeman, G., & Foulon, V. (2012b). Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. International Journal of Clinical Pharmacy, 34(3), 452–459.

Liekens, S., Smits, T., Laekeman, G., & Foulon, V. (2013). A depression training session with consumer educators to reduce stigmatizing views and improve pharmacists’ depression care attitudes and practices. American Journal of Pharmaceutical Education, 77(6), 120.CrossRefPubMedPubMedCentral

Liekens, S., Vandael, E., Roter, D., Larson, S., Smits, T., Laekeman, G., et al. (2014). Impact of training on pharmacists’ counseling of patients starting antidepressant therapy. Patient Education and Counseling, 94(1), 110–115.CrossRefPubMed

Link, B. G., Cullen, F. T., Frank, J., & Wozniak, J. F. (1987). The social rejection of former mental patients: understanding why labels matter. American Journal of Sociology, 92(6), 1461–1500.

Link, B. G., & Phelan, J. C. (2001). Conceptualizing Stigma. Annual Review of Sociology, 27, 363–385. doi:10.1146/annurev.soc.27.1.363.CrossRef

Mojtabai, R., & Olfson, M. (2014). National trends in long-term use of antidepressant medications: Results from the US National Health and Nutrition Examination Survey. Journal of Clinical Psychiatry, 75(2), 169–177.CrossRefPubMed

Nguyen, E., Chen, T. F., & O’Reilly, C. L. (2012). Evaluating the impact of direct and indirect contact on the mental health stigma of pharmacy students. Social Psychiatry and Psychiatric Epidemiology, 47(7), 1087–1098.CrossRefPubMed

O’Donnell, D. C., Brown, C. M., & Dastani, H. B. (2005). Barriers to counseling patients with obesity: A study of Texas community pharmacists. Journal of the American Pharmacists Association: JAPhA, 46(4), 465–471.CrossRef

O’Loughlin, J., Masson, P., Déry, V., & Fagnan, D. (1999). The role of community pharmacists in health education and disease prevention: A survey of their interests and needs in relation to cardiovascular disease. Preventive Medicine, 28(3), 324–331.CrossRefPubMed

O’Reilly, C. L., Bell, J. S., & Chen, T. F. (2010). Consumer-led mental health education for pharmacy students. American Journal of Pharmaceutical Education, 74(9), 167.CrossRefPubMedPubMedCentral

O’Reilly, C. L., Bell, J. S., Kelly, P. J., & Chen, T. F. (2011). Impact of mental health first aid training on pharmacy students’ knowledge, attitudes and self-reported behaviour: a controlled trial. Australian and New Zealand Journal of Psychiatry, 45(7), 549–557. doi:10.3109/00048674.2011.585454.CrossRefPubMed

O’Reilly, C. L., Bell, J. S., Kelly, P. J., & Chen, T. F. (2013). Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Research in Social and Administrative Pharmacy, 11(3), e101–e109.CrossRefPubMed

O’Reilly, C. L., Simon Bell, J., & Chen, T. F. (2010). Pharmacists’ beliefs about treatments and outcomes of mental disorders: A mental health literacy survey. Australian and New Zealand Journal of Psychiatry, 44(12), 1089–1096.CrossRefPubMed

Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H. (2002). National trends in the outpatient treatment of depression. Journal of the American Medical Association, 287(2), 203–209. doi:10.1001/jama.287.2.203.CrossRefPubMed

Patten, S. B., Remillard, A., Phillips, L., Modgill, G., Szeto, A. C., Kassam, A., et al. (2012). Effectiveness of contact-based education for reducing mental illness-related stigma in pharmacy students. BMC Medical Education, 12(1), 120.CrossRefPubMedPubMedCentral

Penn, D. L., Guynan, K., Daily, T., Spaulding, W. D., Garbin, C. P., & Sullivan, M. (1994). Dispelling the stigma of schizophrenia: what sort of information is best? Schizophrenia Bulletin, 20(3), 567–578.CrossRefPubMed

Phokeo, V., Sproule, B., & Raman-Wilms, L. (2004). Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatric Services, 55(12), 1434–1436.CrossRefPubMed

Rickles, N. M., Dube, G. L., McCarter, A., & Olshan, J. S. (2010). Relationship between attitudes toward mental illness and provision of pharmacy services. Journal of the American Pharmacists Association: JAPhA, 50(6), 704.CrossRefPubMed

Rubio-Valera, M., Serrano-Blanco, A., Magdalena-Belío, J., Fernández, A., García-Campayo, J., Pujol, M. M., et al. (2011). Effectiveness of pharmacist care in the improvement of adherence to antidepressants: A systematic review and meta-analysis. Annals of Pharmacotherapy, 45(1), 39–48.CrossRefPubMed

Scheerder, G., De Coster, I., & Van Audenhove, C. (2008). Pharmacists’ role in depression care: A survey of attitudes, current practices, and barriers. Psychiatric Services, 59(10), 1155–1160.CrossRefPubMed

Sheppard, B. H., Hartwick, J., & Warshaw, P. R. (1988). The theory of reasoned action: A meta-analysis of past research with recommendations for modifications and future research. Journal of Consumer Research, 15(3), 325–343.

Siracuse, M. V., Schondelmeyer, S. W., Hadsall, R. S., & Schommer, J. C. (2008). Third-year pharmacy students’ work experience and attitudes and perceptions of the pharmacy profession. American Journal of Pharmaceutical Education, 72(3), 50.

Smith, S. R., Golin, C. E., & Reif, S. (2004). Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications. American Journal of Health-System Pharmacy, 61(11), 1120–1129.PubMed

Stern, T. A., Rosenbaum, J. F., Fava, M., Biederman, J., & Rauch, S. L. (2008). Massachusetts general hospital comprehensive clinical psychiatry (1st ed.). UK: Elsevier Health Sciences.

Svarstad, B. L., Bultman, D. C., & Mount, J. K. (2003). Patient counseling provided in community pharmacies: Effects of state regulation, pharmacist age, and busyness. Journal of the American Pharmacists Association: JAPhA, 44(1), 22–29.

Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., et al. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry, 70(Suppl 4), 1–46.PubMed

Volmer, D., Mäesalu, M., & Bell, J. S. (2008). Pharmacy students’ attitudes toward and professional interactions with people with mental disorders. International Journal of Social Psychiatry, 54(5), 402–413.CrossRefPubMed

Titel: Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students’ Willingness to Counsel People Living with Mental Illness
verfasst von: Benita A. Bamgbade
Jamie C. Barner
Kentya H. Ford
Publikationsdatum: 15.12.2016
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 5/2017
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-016-0075-6

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students’ Willingness to Counsel People Living with Mental Illness

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Beliefs and Prejudices Versus Knowledge and Awareness: How to Cope Stigma Against Mental Illness. A College Staff E-survey

Measuring and Facilitating Client Engagement with Financial Incentives: Implications for Improving Clinical Outcomes in a Mental Health Setting

Peer Support in Full-Service Partnerships: A Multiple Case Study Analysis

What is the Lived Experience of Being Discharged From a Psychiatric Inpatient Stay?

The Reform of Rehabilitation in the Community of Persons with Psychiatric Disabilities: Lessons from the Israeli Experience

Predictors of Mental Health Treatment Seeking and Engagement in a Community Mental Health Center

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie